Microbial cell-free DNA for diagnosis of bacterial and fungal infection in the immunocompromised host – what do we know?
Understanding the current evidence, limitations, and variability surrounding plasma mNGS is essential to guide its appropriate clinical use and to inform future integration into diagnostic pathways for ICHs.
Authors
- Adam G. Stewart (ORCID: https://orcid.org/0000-0002-7262-7529)
- Teny Mathew John (ORCID: https://orcid.org/0000-0002-2675-1529)
- Hazim Allos
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- Harvard University (US)
- Massachusetts General Hospital (US)
Publication Details
- Journal
- Current Opinion in Infectious Diseases
- Published
- 2025-08-22
- DOI
- https://doi.org/10.1097/qco.0000000000001146
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 0.00